Holbrook Kerr

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 39% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Holbrook Kerr's trades of Avanos Medical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-19 2025-11-18
S Sale
48,474 -42.4%
470.14
US$4,442,466 		48,474 -42.4% 470.14 US$4,442,466
2025-11-19 2025-11-18
S Sale
44,938 +27.1%
170.55
US$1,823,022 		44,938 +27.1% 170.55 US$1,823,022
2025-11-19 2025-11-18
S Sale
49,308 -8.0%
266.31
US$4,991,184 		49,308 -8.0% 266.31 US$4,991,184
2025-11-19 2025-11-18
S Sale
13,834 -14.0%
11.00
US$152,174 		13,834 -14.0% 11.00 US$152,174
2025-11-18 2025-11-18
PrS Proposed sale
15,000
11.00
US$165,014 		15,000 11.00 US$165,014
2025-03-10 2025-03-06
S Sale
7,000 -7.9%
15.25
US$106,778 		7,000 -7.9% 15.25 US$106,778
2025-03-06 2025-03-06
PrS Proposed sale
7,000
15.25
US$106,780 		7,000 15.25 US$106,780